2023-20782. Notice Pursuant to The National Cooperative Research and Production Act of 1993-Senior Healthcare Innovation Consortium

Notice is hereby given that, on July 11, 2023, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Senior Healthcare Innovation Consortium (“Senior Healthcare Innovation Consortium”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, CarePredict, Inc., Plantation, FL; International Consulting Associates, Inc., Arlington, VA; Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Novare Products LLC, Bryant, AR; and The Diabetes Resistance LLC, Clawson, MI, have been added as parties to this venture.

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Senior Healthcare Innovation Consortium intends to file additional written notifications disclosing all changes in membership.

On November 02, 2022, Senior Healthcare Innovation Consortium filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on November 23, 2022 (87 FR 71677).

The last notification was filed with the Department on April 12, 2023. A notice was published in the Federal Register pursuant to section 6(b) of the Act on June 13, 2023 (88 FR 38533).

Suzanne Morris,

Deputy Director Civil Enforcement Operations, Antitrust Division.